Amount Raised
$19.2 Million
Round Type
Funding Round
SingaporeBiotechnologyHealth CareScience And EngineeringDescription
Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other investors.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Cargene that raised within 45 days of this round, from Fundz verified event records.
- Septerna raised $100M (Series A) on January 27, 2022.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.
- PostEra Inc. raised $26M on January 14, 2022.
Who to call at Cargene, and when
A new round usually means Cargene is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cargene raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cargene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cargene. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cargene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cargene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.